Britz Lab
6869
44
About Our Lab
Our Team
The Cerebrovascular Research Laboratory studies brain microcirculation in normal and pathological conditions. The brain is critically dependent on a continuous and adequate blood supply for normal functioning, so such catastrophic events like stroke or subarachnoid hemorrhage not only damage the brain, but they lead to abnormalities of cerebrovascular circulation which may aggravate the consequences of the perpetrating event.
Some of the changes in cerebrovascular circulation, however, could be beneficial. In our research, we study the mechanisms that lead to changes in cerebrovascular circulation following the initial insult. We explore which changes in microvascular circulation could actually be beneficial for the following recovery and which have a negative effect on the recovery. We also investigate the mechanisms by which abnormalities of cerebrovascular circulation damage the brain.
In our studies, we employ various in vitro and in vivo techniques to better understand the intimate relations between the initial causes, the changes in microcirculation and the role of the latter in brain damage. The ultimate goal of our studies is to develop new therapeutic approaches for the treatment of various neurological disturbances related to cerebrovascular circulation.
Projects & Highlights
- Hemorrhagic and ischemic strokes
- Subarachnoid hemorrhage
- Neuroprotection
- Traumatic brain injury
- Hemorragic and Ischemic Strokes
In spite of significant efforts to find new therapies, hemorrhagic and ischemic strokes remain in the top 10 causes of long term disability. The Cerebrovascular Research Laboratory is exploring innovative approaches developed in our Laboratory to the preservation of brain tissue following the catastrophic events using neuromodulation and “electroceuticals” tools to activate innate neuroprotective mechanisms. The Laboratory also collaborates with the Neuroregeneration laboratory to explore potential of stem cell therapy to recover damaged brain tissue.
Subarachnoid Hemorrhage
Subarachnoid hemorrhage, the catastrophic event resulting from the rupture of brain aneurism and traumatic damage of large brain surface arteries, leads to long-term or permanent brain damage. One of the factors leading to the long-term brain damage is abnormalities of cerebrospinal fluid flow, which interrupts normal clearance of brain parenchyma from various waste products. In our Laboratory we are exploring the role of innate brain coagulation system in the control of hemorrhage and regulation of cerebral fluid flow. This innovative approach will potentially lead to the development of new therapeutic approaches for the treatment of subarachnoid hemorrhage consequences.
Neuroprotection
Brain is very delicate and depends on the stable continuous supply of oxygen and glucose provided by brain circulation. The complex system has evolved to protect the brain against damage due to inadequate supply of these major elements. This system includes regulation of cerebrovascular flow and the innate neuroprotective mechanisms. This system is activated naturally, for example, during diving or hibernation. Our Laboratory explores methods to protect the brain in various damaging conditions using innovative neuromodulation and electroceuticals approaches.
Traumatic Brain Injury
Traumatic brain injury presents a significant problem for military and civil population. Finding a treatment for this detrimental condition remains a serious challenge. Our Laboratory is developing new ground-breaking neuromodulatory approaches to address this problem.
Our Team
Gavin Britz, Principal Investigator
Dr. Gavin Britz earned his MBBCh at the University of the Witwatersrand School of Medicine, South Africa in 1987. He completed his residency at Johns Hopkins Hospital, Baltimore in neurosurgery. During his residency he attended St. George’s Medical School, The University of London, UK and served as a Neurosurgical Registrar and Senior Registrar. After residency, he took a cerebrovascular fellowship in 2002 and an Interventional Neuroradiology Fellowship in 2003 at the University of Washington Medical School, Seattle. In 2003 he earned his MPH at the University of Washington, Seattle. He also obtained an MBA from George Washington University in 2015. He held faculty appointments at the University of Washington and Duke University before becoming a member of Houston Methodist Research Institute in 2014. In his free time, he loves riding his horses outside of town, playing with his two dobermans and triathlon training.
Eugene Golanov, Director
Eugene Golanov graduated from I.M. Sechenov First Moscow State Medical University (former I.M. Sechenov First Moscow Medical School) and obtained his PhD in normal physiology from the Institute of Normal Physiology in Moscow. After leading the Hypertension Physiology group at All Union Cardiology Research Center he moved to the Division of Neurobiology (Dr. Reis) at Weill Cornell Medical College (New York, NY). After twelve years with Weill Cornell Medical College Dr. Golanov lead research laboratory of the Department of Neurosurgery (Dr. Parent) at the Mississippi Medical Center for three years. The following 6 years Dr. Golanov served as a program director and subject matter expert at the National Institute of Neurological Diseases, NIH, and Stroke and Medical Research and Materiel Command of the Department of Defense. In 2013 he returned to academia. Dr. Golanov academic interests include regulation of cerebral blood flow, innate neuroprotection, stroke, traumatic brain injury.
Donate to Houston Methodist
With your support, Houston Methodist provides exceptional research, education, and care that is truly leading medicine.
Donate Now